Raykov Rosty: insider trades.
Raykov Rosty reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($317K), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Raykov Rosty
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | Other | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Fennec Pharmaceuticals Inc. | S | 10,000 | $12.11 | 124,411 | Form 4 |
| 2026-08-31 | Fennec Pharmaceuticals Inc. | A | 2,778 | $0 | 134,411 | Form 4 |
| 2026-08-03 | Fennec Pharmaceuticals Inc. | S | 10,000 | $9.58 | 131,633 | Form 4 |
| 2026-07-31 | Fennec Pharmaceuticals Inc. | A | 2,778 | $0 | 141,633 | Form 4 |
| 2026-07-01 | Fennec Pharmaceuticals Inc. | A | 2,778 | $0 | 132,857 | Form 4 |
| 2026-07-01 | Fennec Pharmaceuticals Inc. | M | 15,597 | $2.45 | 148,454 | Form 4 |
| 2026-07-01 | Fennec Pharmaceuticals Inc. | S | 9,599 | $10.41 | 138,855 | Form 4 |
Questions
What stock did Raykov Rosty buy or sell?
Raykov Rosty reported 7 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($317K), across 1 company.
Is Raykov Rosty the same person as other filers with this name?
This page covers SEC CIK 1468316 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/raykov-rosty-1468316.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.